Cross-Sector entity
Across a 133-day span, the pace is roughly 1.1 stories per week. The busiest single day carried 9. Pomerantz LLP is most often covered alongside Enphase Energy, which appears in 4 of these 20 stories. Coverage clusters in corporate-law, which accounts for 6 of those 20, with the remainder spread across 7 other categories.
33 verified stories tracked
Last mentioned: Aug 1, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 25 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Across a 133-day span, the pace is roughly 1.1 stories per week. The busiest single day carried 9. Pomerantz LLP is most often covered alongside Enphase Energy, which appears in 4 of these 20 stories. Coverage clusters in corporate-law, which accounts for 6 of those 20, with the remainder spread across 7 other categories. The tracked stories average 3.1 original sources each. This profile follows 20 Cross-Sector stories mentioning Pomerantz LLP across the period from March 22, 2026 to August 1, 2026. 25% of these stories carry negative sentiment.
Computed from the 20 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Pomerantz LLP. Shared-story counts are live from our verified record — not editorial picks.
Initial Court Hearings
Expected timeframe for motions to dismiss and initial discovery phases in the respective district courts.
Discovery Phase
Expected commencement of the discovery process if the cases survive initial motions to dismiss.
Pomerantz LLP Announces Investigations
Pomerantz issues press releases for all five companies, seeking lead plaintiffs for potential securities class actions.
Celsius Texas AG Investigation
Texas AG Paxton announces investigation into Celsius's marketing of high-caffeine drinks to children. Stock falls 7.53%.
Compass Antitrust Probe Disclosure
Media reports NY AG antitrust investigation into Compass's $1.6B acquisition of Anywhere Real Estate. Stock falls 11.82%.
Wise Money Laundering Report
The Bureau of Investigative Journalism reports Belgian probe into Wise accounts used for money laundering. Stock falls 4.63% on June 2.
Photronics Q2 Earnings Miss
Photronics reports Q2 revenue of $209M, down YoY, and operating margin contraction. Stock falls 36.4%.
Gap Inc. Q1 Earnings Miss
Gap reports Q1 revenue of $3.5B, 1% growth YoY, missing estimates; cuts full-year guidance. Stock falls 15.4% on May 29.
Verra Mobility contract termination disclosure
Received Avis Budget Group termination notice effective Sep 2026; revised 2026 outlook downward; cost cuts planned. Stock crashed 70.57% to $3.85 on May 27.
Lead Plaintiff Deadline
Expected deadline for shareholders to petition the court to serve as lead plaintiff in the case.
Lead Plaintiff Deadline
Estimated deadline for shareholders to petition the court to lead the litigation.
Lead Plaintiff Deadline
Final date for investors to apply for lead plaintiff status in the litigation.
GeneDx Q1 2026 results
Adjusted gross margin 74%→69%, FY revenue guide cut to $475–$490M from $540–$555M, and $31.3M impairment on Fabric Genomics. Stock drop implied.
Lead Plaintiff Deadline
Final date for investors to petition the court to serve as lead plaintiff in the consolidated action.
Badger Meter Q1 2026 results
EPS of $0.93 missed by $0.26, revenue of $202.03M missed by $28.58M; utility water sales -10% YoY. Stock fell 24.13% to $115.54.
Lead Plaintiff Deadline (Est)
Anticipated deadline for shareholders to move the court for lead plaintiff appointment.
Secondary Notice
Pomerantz reinforces the filing highlights to ensure broad investor awareness.
Follow-up Disclosure
Secondary announcements highlight the filing and the process for shareholders to join the litigation.
Snowflake Filing
Pomerantz LLP issues formal notice of class action filing against Snowflake Inc.
Legal Alerts
Pomerantz LLP issues shareholder alerts for Driven Brands, CWH, and Apollo.
A newly filed securities class action against BitGo Holdings threatens the crypto custodian's market standing. The lawsuit, alleging misstatements in its IPO documents, has already knocked 6% off BTGO shares and could shake institutional trust in digital asset infrastructure.
Source: prnewswire.com · pr-inside.com
Pomerantz LLP probes Celcuity after FDA-approved breast cancer therapy Revtorpyk sees delayed Q3 2026 commercial launch, sending shares down 17.6%. Analysts question prior launch readiness; health investors weigh biotech regulatory and execution risks.
Source: prnewswire.com
A $31.3 million impairment on the Fabric Genomics deal has drawn a securities lawsuit against GeneDx. For biotech investors, the case highlights the perils of overvalued AI acquisitions in genomics, as GeneDx trimmed its revenue forecast by up to $80 million.
Pomerantz LLP has filed suits against five public companies, alleging securities fraud following dramatic stock declines. With lead plaintiff deadlines in early August 2026, investors must act quickly to recover losses. The cases spotlight disclosure lapses in industries from consumer goods to biotech.
Source: prnewswire.com · prnewswire.com
New York's antitrust investigation into Compass's $1.6 billion acquisition of Anywhere Real Estate has triggered a securities fraud probe by Pomerantz, after the stock plunged 11.82%. The scrutiny could reshape consolidation in residential real estate technology.
Pomerantz LLP launched five securities fraud investigations on a single day, citing stock drops following adverse events. The Compass probe uniquely intertwines antitrust and securities law, while Photronics’ 36.4% crash raises classic disclosure concerns.
Investors in five companies—Compass, Photronics, Celsius, Gap, and Wise—suffered deep one-day losses, collectively wiping out billions, as negative news spurred Pomerantz investigations. The event underscores latent legal risk embedded in equity holdings.
Source: prnewswire.com · prnewswire.com
Navan reported a surprise profit in Q4 2026, with revenue reaching $178 million and a positive EPS of $0.02. The company is doubling down on AI-driven travel management and expects 24% growth in 2027, despite ongoing investor litigation.
Source: fool.com · seekingalpha.com
Pomerantz LLP has initiated a class action lawsuit against Boston Scientific (BSX), alleging potential violations of federal securities laws. The litigation centers on the company's disclosures during a period of significant expansion and product integration, marking a critical legal challenge for the medical device giant.
Pomerantz LLP has initiated a class action investigation and filing against Boston Scientific Corporation (BSX), alleging the medical device giant made misleading statements regarding its clinical trials and business prospects. The litigation follows a period of heightened volatility for the company's cardiovascular portfolio, specifically concerning the FARAPULSE PFA system and recent trial adjustments.
Pomerantz LLP has issued a formal notice regarding a class action lawsuit against Boston Scientific Corporation (BSX), alleging potential securities fraud. The litigation focuses on whether the medical technology giant made misleading statements regarding its product pipeline or regulatory compliance during the class period.
Source: pr-inside.com · pr-inside.com
Pomerantz LLP has issued formal reminders regarding class action lawsuits filed against Richtech Robotics and Mereo BioPharma, alleging securities fraud and misleading disclosures. These legal maneuvers highlight the increasing scrutiny on post-IPO startups and clinical-stage biotech firms facing market volatility.
Pomerantz LLP has issued a formal reminder regarding a class-action lawsuit filed against Mereo BioPharma Group plc, alleging potential violations of federal securities laws. The legal action focuses on whether the company made misleading statements or failed to disclose material facts regarding its clinical operations and financial outlook.
Pomerantz LLP has issued formal reminders regarding class action lawsuits filed against Mereo BioPharma and Richtech Robotics, signaling a surge in securities litigation within the biotech and automation sectors. These legal actions focus on alleged violations of federal securities laws, specifically regarding material misstatements that impacted investor valuations.
Source: pr-inside.com · pr-inside.com
Pomerantz LLP has initiated class action litigation against Nektar Therapeutics and Enphase Energy, alleging securities fraud and misleading statements. These filings highlight a growing trend of legal scrutiny in the biotech and renewable energy sectors as companies navigate volatile market conditions and regulatory shifts.
Pomerantz LLP has filed a class action lawsuit against solar technology leader Enphase Energy, alleging securities law violations following a period of significant stock volatility. The litigation marks a critical regulatory challenge for the renewable energy sector as it navigates a broader market downturn.
Pomerantz LLP has initiated class action litigation against Nektar Therapeutics, alleging the company made false or misleading statements regarding its clinical programs and business prospects. The lawsuit seeks to recover damages for investors following significant stock volatility linked to the company's oncology pipeline performance.
Pomerantz LLP has issued urgent alerts to investors regarding class action lawsuits against Driven Brands, Apollo, and Camping World Holdings. These legal actions focus on alleged securities fraud and failures to disclose material information, potentially impacting institutional and retail recovery efforts.
Pomerantz LLP has initiated class action lawsuits against Nektar Therapeutics and Enphase Energy, alleging violations of federal securities laws. The litigation follows a series of financial disclosures and regulatory filings in early 2026 that triggered significant market volatility for both companies.
Source: pr-inside.com · pr-inside.com
Pomerantz LLP has issued a series of alerts to shareholders regarding potential class action lawsuits against Driven Brands, Camping World Holdings, and Apollo-affiliated entities. The litigation follows significant financial disclosures, including Driven Brands' admission of material errors in prior financial statements.
Source: pr-inside.com · pr-inside.com
